Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
16
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| BAMFORD PASCAL | Chief Clinical Officer | 11 | $0 | $0 | 2025-07-08 |
| Kamocsay Jennifer | General Counsel | 13 | $0 | $0 | 2025-07-08 |
| McKelligon Brian | President/CEO | 65 | $0 | $490.7K | 2025-07-08 |
| Ramachandran Niro Ph.D | Chief Business Officer | 27 | $329.2K | $0 | 2025-07-08 |
| Ek John Frederick | CFO | 14 | $100.0K | $0 | 2025-07-08 |
| Winkler Matthew | Director | 10 | $1.02M | $0 | 2025-07-08 |
| Mendel Scott | Director | 13 | $211.9K | $0 | 2025-07-08 |
| Raffin Thomas A. | Director, 10% Owner | 14 | $10.10M | $0 | 2025-07-08 |
| SCHNETTLER THOMAS P | Director | 9 | $0 | $925.8K | 2025-07-08 |
| LAI GOLDMAN MYLA | Director | 10 | $100.0K | $0 | 2025-07-08 |
| SHEPLER ROBERT G | Director | 13 | $1.04M | $0 | 2025-07-08 |
| Pla Frederic | Chief Operating Officer | 12 | $92.0K | $0 | 2024-03-23 |
| Nolan Garry Ph.D. | Director | 15 | $0 | $1.16M | 2023-06-01 |
| El-Gabry Ehab | Chief Medical Officer | 3 | $0 | $0 | 2023-02-23 |
| Moy Marilee | Chief People Officer | 3 | $0 | $0 | 2023-02-23 |
| DRISCOLL JOSEPH | Chief Financial Officer | 10 | $0 | $308.8K | 2022-12-22 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| LAI GOLDMAN MYLA | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 30,549 | — | $0 | 0 | SEC↗ |
| LAI GOLDMAN MYLA | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 56,322 | — | $0 | 0 | SEC↗ |
| LAI GOLDMAN MYLA | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 50,000 | — | $0 | 0 | SEC↗ |
| LAI GOLDMAN MYLA | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 38,993 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 50,000 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 16,860 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 56,322 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 30,549 | — | $0 | 0 | SEC↗ |
| SCHNETTLER THOMAS P | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 16,860 | — | $0 | 0 | SEC↗ |
| SCHNETTLER THOMAS P | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 50,000 | — | $0 | 0 | SEC↗ |
| SCHNETTLER THOMAS P | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 30,549 | — | $0 | 0 | SEC↗ |
| SCHNETTLER THOMAS P | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 56,322 | — | $0 | 0 | SEC↗ |
| SHEPLER ROBERT G | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 16,860 | — | $0 | 0 | SEC↗ |
| SHEPLER ROBERT G | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 50,000 | — | $0 | 0 | SEC↗ |
| SHEPLER ROBERT G | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 30,549 | — | $0 | 0 | SEC↗ |
| SHEPLER ROBERT G | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 56,322 | — | $0 | 0 | SEC↗ |
| Winkler Matthew | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 50,000 | — | $0 | 0 | SEC↗ |
| Winkler Matthew | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 56,322 | — | $0 | 0 | SEC↗ |
| Winkler Matthew | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 30,549 | — | $0 | 0 | SEC↗ |
| Winkler Matthew | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 16,860 | — | $0 | 0 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 150,000 | — | $0 | 0 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 25,000 | — | $0 | 0 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 15,000 | — | $0 | 0 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 50,000 | — | $0 | 0 | SEC↗ |
| Ek John Frederick | CFO | J Other deriv | 2025-07-08 | 2025-07-10 | 160,000 | — | $0 | 0 | SEC↗ |
| Ek John Frederick | CFO | J Other deriv | 2025-07-08 | 2025-07-10 | 70,000 | — | $0 | 0 | SEC↗ |
| Kamocsay Jennifer | Chief Legal Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 70,000 | — | $0 | 0 | SEC↗ |
| Kamocsay Jennifer | Chief Legal Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 75,000 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | J Other deriv | 2025-07-08 | 2025-07-10 | 175,000 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | J Other deriv | 2025-07-08 | 2025-07-10 | 160,000 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | J Other deriv | 2025-07-08 | 2025-07-10 | 160,000 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | J Other deriv | 2025-07-08 | 2025-07-10 | 241,592 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | J Other deriv | 2025-07-08 | 2025-07-10 | 393,338 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | J Other deriv | 2025-07-08 | 2025-07-10 | 331,090 | — | $0 | 0 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 62,566 | — | $0 | 0 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 45,000 | — | $0 | 0 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 45,000 | — | $0 | 0 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | J Other deriv | 2025-07-08 | 2025-07-10 | 70,000 | — | $0 | 0 | SEC↗ |
| Mendel Scott | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 35,562 | — | $0 | 0 | SEC↗ |
| Mendel Scott | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 30,549 | — | $0 | 0 | SEC↗ |
| Mendel Scott | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 56,322 | — | $0 | 0 | SEC↗ |
| Mendel Scott | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 44,959 | — | $0 | 0 | SEC↗ |
| Mendel Scott | Director | J Other deriv | 2025-07-08 | 2025-07-10 | 50,000 | — | $0 | 0 | SEC↗ |
| LAI GOLDMAN MYLA | Director | J Other | 2025-07-08 | 2025-07-10 | 20,000 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | J Other | 2025-07-08 | 2025-07-10 | 234,592 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | J Other | 2025-07-08 | 2025-07-10 | 1,737,712 | — | $0 | 0 | SEC↗ |
| Raffin Thomas A. | Director | J Other | 2025-07-08 | 2025-07-10 | 15,937,535 | — | $0 | 0 | SEC↗ |
| Winkler Matthew | Director | J Other | 2025-07-08 | 2025-07-10 | 984,513 | — | $0 | 0 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | J Other | 2025-07-08 | 2025-07-10 | 9,488 | — | $0 | 196,250 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | J Other | 2025-07-08 | 2025-07-10 | 196,250 | — | $0 | 0 | SEC↗ |
| Ek John Frederick | CFO | J Other | 2025-07-08 | 2025-07-10 | 193,750 | — | $0 | 0 | SEC↗ |
| Ek John Frederick | CFO | J Other | 2025-07-08 | 2025-07-10 | 20,000 | — | $0 | 0 | SEC↗ |
| Ek John Frederick | CFO | J Other | 2025-07-08 | 2025-07-10 | 54,452 | — | $0 | 193,750 | SEC↗ |
| Kamocsay Jennifer | Chief Legal Officer | J Other | 2025-07-08 | 2025-07-10 | 16,772 | — | $0 | 162,500 | SEC↗ |
| Kamocsay Jennifer | Chief Legal Officer | J Other | 2025-07-08 | 2025-07-10 | 162,500 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | J Other | 2025-07-08 | 2025-07-10 | 947,688 | — | $0 | 0 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2025-07-08 | 2025-07-10 | 196,866 | — | $0 | 947,688 | SEC↗ |
| McKelligon Brian | President and CEO | J Other | 2025-07-08 | 2025-07-10 | 393,338 | — | $0 | 813,464 | SEC↗ |
| McKelligon Brian | President and CEO | J Other | 2025-07-08 | 2025-07-10 | 331,090 | — | $0 | 1,144,554 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | J Other | 2025-07-08 | 2025-07-10 | 62,566 | — | $0 | 324,703 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | F Tax w/h | 2025-07-08 | 2025-07-10 | 42,148 | — | $0 | 282,555 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | J Other | 2025-07-08 | 2025-07-10 | 130,625 | — | $0 | 0 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | J Other | 2025-07-08 | 2025-07-10 | 151,930 | — | $0 | 130,625 | SEC↗ |
| Mendel Scott | Director | J Other | 2025-07-08 | 2025-07-10 | 28,500 | — | $0 | 0 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | F Tax w/h | 2025-06-01 | 2025-06-02 | 670 | $1.25 | $838 | 205,738 | SEC↗ |
| Ek John Frederick | CFO | F Tax w/h | 2025-04-01 | 2025-04-03 | 16,432 | $1.35 | $22.2K | 248,202 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | F Tax w/h | 2025-03-23 | 2025-03-25 | 2,310 | $1.70 | $3.9K | 287,210 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2025-03-23 | 2025-03-25 | 7,550 | $1.70 | $12.8K | 420,126 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2025-03-01 | 2025-03-04 | 8,257 | $1.63 | $13.5K | 427,676 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2025-03-01 | 2025-03-04 | 7,550 | $1.63 | $12.3K | 435,933 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | F Tax w/h | 2025-03-01 | 2025-03-04 | 2,310 | $1.63 | $3.8K | 293,114 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | F Tax w/h | 2025-03-01 | 2025-03-04 | 3,594 | $1.63 | $5.9K | 289,520 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | F Tax w/h | 2025-03-01 | 2025-03-04 | 2,567 | $1.63 | $4.2K | 206,408 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | F Tax w/h | 2025-03-01 | 2025-03-04 | 1,283 | $1.63 | $2.1K | 208,975 | SEC↗ |
| Ek John Frederick | CFO | F Tax w/h | 2025-03-01 | 2025-03-04 | 3,594 | $1.63 | $5.9K | 264,634 | SEC↗ |
| Kamocsay Jennifer | Chief Legal Officer | F Tax w/h | 2025-03-01 | 2025-03-04 | 3,851 | $1.63 | $6.3K | 182,866 | SEC↗ |
| Kamocsay Jennifer | Chief Legal Officer | F Tax w/h | 2025-03-01 | 2025-03-04 | 3,594 | $1.63 | $5.9K | 179,272 | SEC↗ |
| McKelligon Brian | President and CEO | A Award | 2024-11-19 | 2024-11-21 | 218,750 | — | $0 | 443,483 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | A Award | 2024-11-19 | 2024-11-21 | 87,500 | — | $0 | 295,424 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | A Award | 2024-11-19 | 2024-11-21 | 87,500 | — | $0 | 210,258 | SEC↗ |
| Ek John Frederick | CFO | A Award | 2024-11-19 | 2024-11-21 | 87,500 | — | $0 | 268,228 | SEC↗ |
| Kamocsay Jennifer | Chief Legal Officer | A Award | 2024-11-19 | 2024-11-21 | 87,500 | — | $0 | 186,717 | SEC↗ |
| Mendel Scott | Director | A Award deriv | 2024-10-02 | 2024-10-04 | 44,959 | — | $0 | 44,959 | SEC↗ |
| BAMFORD PASCAL | Chief Clinical Officer | A Award | 2024-08-29 | 2024-09-03 | 40,000 | — | $0 | 122,758 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise deriv | 2024-06-11 | 2024-06-12 | 7,500 | — | $0 | 275,629 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise | 2024-06-11 | 2024-06-12 | 7,500 | $0.30 | $2.3K | 232,233 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2024-06-11 | 2024-06-12 | 7,500 | $2.08 | $15.6K | 224,733 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise deriv | 2024-06-06 | 2024-06-07 | 7,500 | — | $0 | 283,129 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2024-06-06 | 2024-06-07 | 7,500 | $2.01 | $15.1K | 224,733 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise | 2024-06-06 | 2024-06-07 | 7,500 | $0.30 | $2.3K | 232,233 | SEC↗ |
| Mendel Scott | Director | A Award deriv | 2024-06-04 | 2024-06-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| LAI GOLDMAN MYLA | Director | A Award deriv | 2024-06-04 | 2024-06-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SCHNETTLER THOMAS P | Director | A Award deriv | 2024-06-04 | 2024-06-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Winkler Matthew | Director | A Award deriv | 2024-06-04 | 2024-06-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SHEPLER ROBERT G | Director | A Award deriv | 2024-06-04 | 2024-06-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2024-06-04 | 2024-06-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Ek John Frederick | CFO | F Tax w/h | 2024-04-01 | 2024-04-02 | 14,272 | $4.56 | $65.1K | 180,728 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2024-03-23 | 2024-03-25 | 7,135 | $4.79 | $34.2K | 224,733 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | F Tax w/h | 2024-03-23 | 2024-03-25 | 2,006 | $4.79 | $9.6K | 207,924 | SEC↗ |
| Pla Frederic | Chief Operating Officer | F Tax w/h | 2024-03-23 | 2024-03-25 | 2,006 | $4.79 | $9.6K | 101,500 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise deriv | 2024-03-20 | 2024-03-22 | 7,500 | — | $0 | 290,629 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise | 2024-03-20 | 2024-03-22 | 7,500 | $0.30 | $2.3K | 239,368 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2024-03-20 | 2024-03-22 | 7,500 | $4.97 | $37.3K | 231,868 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise deriv | 2024-03-13 | 2024-03-22 | 7,500 | — | $0 | 298,129 | SEC↗ |
| SHEPLER ROBERT G | Director | G Gift | 2024-03-13 | 2024-03-14 | 369,592 | — | $0 | 0 | SEC↗ |
| SHEPLER ROBERT G | Director | G Gift | 2024-03-13 | 2024-03-14 | 369,592 | — | $0 | 369,592 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2024-03-13 | 2024-03-14 | 7,500 | $4.94 | $37.0K | 224,368 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise | 2024-03-13 | 2024-03-22 | 7,500 | $0.30 | $2.3K | 239,368 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2024-03-13 | 2024-03-22 | 7,500 | $4.94 | $37.0K | 231,868 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2024-03-01 | 2024-03-01 | 2,049 | $6.03 | $12.4K | 103,506 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2024-03-01 | 2024-03-01 | 8,195 | $6.03 | $49.4K | 231,868 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | F Tax w/h | 2024-03-01 | 2024-03-01 | 2,305 | $6.03 | $13.9K | 209,930 | SEC↗ |
| Pla Frederic | Chief Operating Officer | F Tax w/h | 2024-03-01 | 2024-03-01 | 2,049 | $6.03 | $12.4K | 103,506 | SEC↗ |
| Kamocsay Jennifer | General Counsel | F Tax w/h | 2024-03-01 | 2024-03-01 | 3,283 | $6.03 | $19.8K | 99,217 | SEC↗ |
| McKelligon Brian | President and CEO | F Tax w/h | 2024-03-01 | 2024-03-04 | 8,195 | $6.03 | $49.4K | 231,868 | SEC↗ |
| McKelligon Brian | President and CEO | A Award deriv | 2024-02-22 | 2024-03-01 | 175,000 | — | $0 | 175,000 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | A Award deriv | 2024-02-22 | 2024-03-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Pla Frederic | Chief Operating Officer | A Award deriv | 2024-02-22 | 2024-03-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Kamocsay Jennifer | General Counsel | A Award deriv | 2024-02-22 | 2024-03-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| Ek John Frederick | CFO | A Award deriv | 2024-02-22 | 2024-03-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| McKelligon Brian | President and CEO | A Award deriv | 2024-02-22 | 2024-03-04 | 175,000 | — | $0 | 175,000 | SEC↗ |
| McKelligon Brian | President and CEO | A Award | 2024-02-22 | 2024-03-01 | 87,500 | — | $0 | 240,063 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | A Award | 2024-02-22 | 2024-03-01 | 35,000 | — | $0 | 212,235 | SEC↗ |
| Pla Frederic | Chief Operating Officer | A Award | 2024-02-22 | 2024-03-01 | 35,000 | — | $0 | 105,555 | SEC↗ |
| Kamocsay Jennifer | General Counsel | A Award | 2024-02-22 | 2024-03-01 | 35,000 | — | $0 | 102,500 | SEC↗ |
| Ek John Frederick | CFO | A Award | 2024-02-22 | 2024-03-01 | 35,000 | — | $0 | 195,000 | SEC↗ |
| McKelligon Brian | President and CEO | A Award | 2024-02-22 | 2024-03-04 | 87,500 | — | $0 | 240,063 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise deriv | 2023-12-19 | 2023-12-20 | 7,500 | — | $0 | 305,629 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise | 2023-12-19 | 2023-12-20 | 7,500 | $0.30 | $2.3K | 160,063 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2023-12-19 | 2023-12-20 | 7,500 | $4.48 | $33.6K | 152,563 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise deriv | 2023-12-12 | 2023-12-14 | 7,500 | — | $0 | 313,129 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2023-12-12 | 2023-12-14 | 7,500 | $4.25 | $31.9K | 152,563 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise | 2023-12-12 | 2023-12-14 | 7,500 | $0.30 | $2.3K | 160,063 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise deriv | 2023-11-20 | 2023-11-22 | 7,500 | — | $0 | 320,629 | SEC↗ |
| McKelligon Brian | President and CEO | M Exercise | 2023-11-20 | 2023-11-22 | 7,500 | $0.30 | $2.3K | 160,063 | SEC↗ |
| McKelligon Brian | President and CEO | S Sale | 2023-11-20 | 2023-11-22 | 7,500 | $4.39 | $32.9K | 152,563 | SEC↗ |
| Kamocsay Jennifer | General Counsel | A Award | 2023-11-06 | 2023-11-27 | 30,000 | — | $0 | 67,500 | SEC↗ |
| Pla Frederic | Chief Operating Officer | A Award | 2023-11-06 | 2023-11-27 | 30,000 | — | $0 | 70,555 | SEC↗ |
| Pla Frederic | Chief Operating Officer | P Buy | 2023-09-07 | 2023-09-11 | 7,000 | $4.60 | $32.2K | 20,000 | SEC↗ |
| Pla Frederic | Chief Operating Officer | P Buy | 2023-09-07 | 2023-09-11 | 13,000 | $4.60 | $59.8K | 13,000 | SEC↗ |
| Raffin Thomas A. | Director | P Buy | 2023-06-12 | 2023-06-12 | 20,000 | $5.00 | $100.0K | 234,592 | SEC↗ |
| Raffin Thomas A. | Director | P Buy | 2023-06-12 | 2023-06-12 | 196,627 | $5.00 | $983.1K | 1,737,712 | SEC↗ |
| Raffin Thomas A. | Director | P Buy | 2023-06-12 | 2023-06-12 | 1,803,373 | $5.00 | $9.02M | 15,937,535 | SEC↗ |
| SHEPLER ROBERT G | Director | P Buy | 2023-06-12 | 2023-06-12 | 120,000 | $5.00 | $600.0K | 369,592 | SEC↗ |
| Winkler Matthew | Director | P Buy | 2023-06-12 | 2023-06-12 | 203,388 | $5.00 | $1.02M | 984,513 | SEC↗ |
| Mendel Scott | Director | P Buy | 2023-06-12 | 2023-06-12 | 20,000 | $5.00 | $100.0K | 28,500 | SEC↗ |
| LAI GOLDMAN MYLA | Director | P Buy | 2023-06-12 | 2023-06-12 | 20,000 | $5.00 | $100.0K | 20,000 | SEC↗ |
| Ek John Frederick | CFO | P Buy | 2023-06-12 | 2023-06-12 | 20,000 | $5.00 | $100.0K | 20,000 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise deriv | 2023-06-06 | 2023-06-06 | 5,000 | — | $0 | 328,129 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise | 2023-06-06 | 2023-06-06 | 5,000 | $0.30 | $1.5K | 157,563 | SEC↗ |
| McKelligon Brian | President/CEO | S Sale | 2023-06-06 | 2023-06-06 | 5,000 | $5.71 | $28.6K | 152,563 | SEC↗ |
| Nolan Garry Ph.D. | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 56,322 | — | $0 | 56,322 | SEC↗ |
| SCHNETTLER THOMAS P | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 56,322 | — | $0 | 56,322 | SEC↗ |
| SHEPLER ROBERT G | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 56,322 | — | $0 | 56,322 | SEC↗ |
| Mendel Scott | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 56,322 | — | $0 | 56,322 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 56,322 | — | $0 | 56,322 | SEC↗ |
| LAI GOLDMAN MYLA | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 56,322 | — | $0 | 56,322 | SEC↗ |
| Winkler Matthew | Director | A Award deriv | 2023-06-01 | 2023-06-05 | 56,322 | — | $0 | 56,322 | SEC↗ |
| McKelligon Brian | President/CEO | F Tax w/h | 2023-03-23 | 2023-03-27 | 7,437 | $7.69 | $57.2K | 152,563 | SEC↗ |
| Pla Frederic | Chief Operating Officer | F Tax w/h | 2023-03-23 | 2023-03-27 | 1,945 | $7.69 | $15.0K | 40,555 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | F Tax w/h | 2023-03-23 | 2023-03-27 | 1,945 | $7.69 | $15.0K | 177,235 | SEC↗ |
| Ek John Frederick | CFO | A Award deriv | 2023-03-20 | 2023-03-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Kamocsay Jennifer | General Counsel | A Award deriv | 2023-03-20 | 2023-03-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Ek John Frederick | CFO | A Award | 2023-03-20 | 2023-03-21 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Kamocsay Jennifer | General Counsel | A Award | 2023-03-20 | 2023-03-21 | 37,500 | — | $0 | 37,500 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise deriv | 2023-03-14 | 2023-03-16 | 5,000 | — | $0 | 333,129 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise | 2023-03-14 | 2023-03-16 | 5,000 | $0.30 | $1.5K | 165,000 | SEC↗ |
| McKelligon Brian | President/CEO | S Sale | 2023-03-14 | 2023-03-16 | 4,774 | $9.14 | $43.6K | 160,226 | SEC↗ |
| McKelligon Brian | President/CEO | S Sale | 2023-03-14 | 2023-03-16 | 226 | $9.92 | $2.2K | 160,000 | SEC↗ |
| Moy Marilee | CHIEF PEOPLE OFFICER | A Award deriv | 2023-02-23 | 2023-02-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| McKelligon Brian | President/CEO | A Award deriv | 2023-02-23 | 2023-02-27 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Pla Frederic | Chief Operating Officer | A Award deriv | 2023-02-23 | 2023-02-27 | 40,000 | — | $0 | 40,000 | SEC↗ |
| El-Gabry Ehab | Chief Medical Officer | A Award deriv | 2023-02-23 | 2023-02-27 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | A Award deriv | 2023-02-23 | 2023-02-27 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Moy Marilee | CHIEF PEOPLE OFFICER | A Award | 2023-02-23 | 2023-02-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| McKelligon Brian | President/CEO | A Award | 2023-02-23 | 2023-02-27 | 80,000 | — | $0 | 160,000 | SEC↗ |
| Pla Frederic | Chief Operating Officer | A Award | 2023-02-23 | 2023-02-27 | 20,000 | — | $0 | 42,500 | SEC↗ |
| El-Gabry Ehab | Chief Medical Officer | A Award | 2023-02-23 | 2023-02-27 | 16,250 | — | $0 | 16,250 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | A Award | 2023-02-23 | 2023-02-27 | 22,500 | — | $0 | 179,180 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | M Exercise deriv | 2023-02-15 | 2023-02-17 | 34,000 | — | $0 | 62,566 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | M Exercise | 2023-02-15 | 2023-02-17 | 34,000 | $0.91 | $30.9K | 156,680 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | M Exercise deriv | 2022-12-22 | 2022-12-27 | 250,000 | — | $0 | 110,958 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | M Exercise | 2022-12-22 | 2022-12-27 | 250,000 | $0.44 | $110.0K | 262,500 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | M Exercise deriv | 2022-12-14 | 2022-12-16 | 10,039 | — | $0 | 123,466 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | M Exercise deriv | 2022-12-14 | 2022-12-16 | 14,574 | — | $0 | 108,712 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | S Sale | 2022-12-14 | 2022-12-16 | 10,039 | $12.67 | $127.2K | 12,500 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | S Sale | 2022-12-14 | 2022-12-16 | 14,574 | $12.46 | $181.6K | 12,500 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | M Exercise | 2022-12-14 | 2022-12-16 | 14,574 | $0.44 | $6.4K | 27,074 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | M Exercise | 2022-12-14 | 2022-12-16 | 10,039 | $0.44 | $4.4K | 22,539 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-12-13 | 2023-03-27 | 100 | $13.25 | $1.3K | 555,084 | SEC↗ |
| SCHNETTLER THOMAS P | Director | S Sale | 2022-12-13 | 2022-12-20 | 71,050 | $13.03 | $925.8K | 2,742,721 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise deriv | 2022-12-06 | 2022-12-08 | 5,000 | — | $0 | 338,129 | SEC↗ |
| McKelligon Brian | President/CEO | S Sale | 2022-12-06 | 2022-12-08 | 5,000 | $12.08 | $60.4K | 80,000 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise | 2022-12-06 | 2022-12-08 | 5,000 | $0.30 | $1.5K | 85,000 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-12-02 | 2022-12-06 | 1,100 | $13.25 | $14.6K | 591,978 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-12-01 | 2022-12-02 | 5,000 | $13.36 | $66.8K | 593,078 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-11-16 | 2022-11-17 | 300 | $13.25 | $4.0K | 598,078 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-11-14 | 2022-11-14 | 600 | $13.28 | $8.0K | 598,378 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-11-11 | 2022-11-14 | 20,000 | $13.29 | $265.8K | 598,978 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-11-10 | 2022-11-14 | 3,810 | $13.31 | $50.7K | 618,978 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-09-14 | 2022-09-16 | 8,305 | $13.26 | $110.1K | 622,788 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-09-12 | 2022-09-13 | 1,800 | $13.30 | $23.9K | 631,093 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2022-09-09 | 2022-09-13 | 22,191 | $13.31 | $295.4K | 632,893 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise deriv | 2022-09-07 | 2022-09-09 | 5,000 | — | $0 | 343,129 | SEC↗ |
| McKelligon Brian | President/CEO | S Sale | 2022-09-07 | 2022-09-09 | 5,000 | $12.83 | $64.2K | 80,000 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise | 2022-09-07 | 2022-09-09 | 5,000 | $0.30 | $1.5K | 85,000 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise deriv | 2022-06-15 | 2022-06-17 | 5,000 | — | $0 | 348,129 | SEC↗ |
| McKelligon Brian | President/CEO | S Sale | 2022-06-15 | 2022-06-17 | 5,000 | $10.25 | $51.3K | 80,000 | SEC↗ |
| McKelligon Brian | President/CEO | M Exercise | 2022-06-15 | 2022-06-17 | 5,000 | $0.30 | $1.5K | 85,000 | SEC↗ |
| Nolan Garry Ph.D. | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 30,549 | — | $0 | 30,549 | SEC↗ |
| Mendel Scott | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 30,549 | — | $0 | 30,549 | SEC↗ |
| Raffin Thomas A. | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 30,549 | — | $0 | 30,549 | SEC↗ |
| SHEPLER ROBERT G | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 30,549 | — | $0 | 30,549 | SEC↗ |
| LAI GOLDMAN MYLA | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 30,549 | — | $0 | 30,549 | SEC↗ |
| Winkler Matthew | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 30,549 | — | $0 | 30,549 | SEC↗ |
| SCHNETTLER THOMAS P | Director | A Award deriv | 2022-06-01 | 2022-06-03 | 30,549 | — | $0 | 30,549 | SEC↗ |
| El-Gabry Ehab | Chief Medical Officer | A Award deriv | 2022-05-19 | 2022-05-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | M Exercise deriv | 2022-04-13 | 2022-04-14 | 75,107 | — | $0 | 96,566 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | M Exercise | 2022-04-13 | 2022-04-14 | 75,107 | $0.91 | $68.3K | 122,680 | SEC↗ |
| Pla Frederic | Chief Operating Officer | A Award deriv | 2022-03-23 | 2022-03-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | A Award deriv | 2022-03-23 | 2022-03-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | A Award deriv | 2022-03-23 | 2022-03-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| McKelligon Brian | President/CEO | A Award deriv | 2022-03-23 | 2022-03-25 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Pla Frederic | Chief Operating Officer | A Award | 2022-03-23 | 2022-03-25 | 22,500 | — | $0 | 22,500 | SEC↗ |
| DRISCOLL JOSEPH | Chief Financial Officer | A Award | 2022-03-23 | 2022-03-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | A Award | 2022-03-23 | 2022-03-25 | 22,500 | — | $0 | 47,573 | SEC↗ |
| McKelligon Brian | President/CEO | A Award | 2022-03-23 | 2022-03-25 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Moy Marilee | Chief People Officer | A Award deriv | 2022-02-24 | 2022-02-28 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2021-12-13 | 2022-12-15 | 100 | $13.25 | $1.3K | 555,084 | SEC↗ |
| Nolan Garry Ph.D. | Director | S Sale | 2021-12-09 | 2021-12-13 | 25,000 | $12.67 | $316.8K | 655,084 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | P Buy | 2021-11-22 | 2021-11-22 | 25,000 | $13.13 | $328.3K | 25,073 | SEC↗ |
| Mendel Scott | Director | P Buy | 2021-11-19 | 2021-11-19 | 8,500 | $13.16 | $111.9K | 8,500 | SEC↗ |
| Ramachandran Niro Ph.D | Chief Business Officer | P Buy | 2021-11-19 | 2021-11-22 | 73 | $12.85 | $938 | 73 | SEC↗ |
| SHEPLER ROBERT G | Director | P Buy | 2021-11-18 | 2021-11-18 | 15,000 | $12.17 | $182.6K | 15,000 | SEC↗ |
| SHEPLER ROBERT G | Director | P Buy | 2021-11-18 | 2021-11-18 | 20,000 | $12.93 | $258.6K | 35,000 | SEC↗ |
| LAI GOLDMAN MYLA | Director | A Award deriv | 2021-09-16 | 2021-09-20 | 38,993 | — | $0 | 38,993 | SEC↗ |
| Mendel Scott | Director | A Award deriv | 2021-06-11 | 2021-06-15 | 35,562 | — | $0 | 35,562 | SEC↗ |
| Nolan Garry Ph.D. | Director | A Award deriv | 2021-05-21 | 2021-05-25 | 16,860 | — | $0 | 16,860 | SEC↗ |
| SHEPLER ROBERT G | Director | A Award deriv | 2021-05-21 | 2021-05-25 | 16,860 | — | $0 | 16,860 | SEC↗ |
| Raffin Thomas A. | Director, 10% Owner | A Award deriv | 2021-05-21 | 2021-05-25 | 16,860 | — | $0 | 16,860 | SEC↗ |
| SCHNETTLER THOMAS P | Director | A Award deriv | 2021-05-21 | 2021-05-25 | 16,860 | — | $0 | 16,860 | SEC↗ |
| Winkler Matthew | Director | A Award deriv | 2021-05-21 | 2021-05-25 | 16,860 | — | $0 | 16,860 | SEC↗ |